Yun et al. reported in this regard that vitamin C could selectively kill KRAS and BRAF mutant colorectal cancer cells via the inactivation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH). This evidence concerns the gene GAPDH and colorectal cancer.